Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1717095

registered interest
date	10/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ritlecitinib: Shropshire
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when she expects Litfulo to be made available to NHS patients in (a) Shropshire, (b) Telford and (c) Wrekin.
tabling member constituency	The Wrekin
tabling member printed	Mark Pritchard
uin	25645
answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) makes recommendations on whether all new licensed medicines should be routinely funded by the National Health Service, based on an assessment of their costs and benefits.</p><p>On 27 March 2024, NICE published final technology appraisal guidance recommending ritlecitinib (Litfulo) for treating severe alopecia areata in people 12 years old and over. The NHS in England is legally required to fund medicines recommended by NICE within three months of the publication of its final guidance.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 14/05/2024 16:53:44 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1576 label Biography information for Mark Pritchard

1717152

registered interest
date	10/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Operating Costs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the annual running costs were for NHS (a) Arden and GEM, (b) Midlands and Lancashire, (c) North of England and (d) South, Central and West Commissioning Support Unit in the 2022-23 financial year.
tabling member constituency	Bristol South
tabling member printed	Karin Smyth
uin	25658
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>The Department does not hold the information requested. Commissioning Support Units (CSUs) form part of one service provided to Clinical Commissioning Groups and integrated care boards by NHS England. CSUs are not separate legal entities, and spending forms part of NHS England’s parent accounts.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/05/2024 08:43:57 answering member 4044 label Biography information for Andrew Stephenson previous answer version 34275 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
tabling member	4444 label Biography information for Karin Smyth

1717158

registered interest
date	10/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Joint Replacements: Post-operative Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether her Department has made a recent assessment of the potential merits of adopting the (a) Infection & Orthopaedic Management (INFORM), (b) British Orthopaedic Association and (c) other guidelines for the treatment and management of prosthetic joint infections.
tabling member constituency	Hayes and Harlington
tabling member printed	John McDonnell
uin	25603
answer	answer is ministerial correction date of answer 17/05/2024 answer text <p>The UK Health Security Agency manages a national surveillance programme, the Surgical Site Infection (SSI) Surveillance Service, which enhances the quality of patient care by providing hospitals with a framework for collection and comparison of their rates of SSI against national benchmarks. This information is used to review and guide clinical practice, to reduce the risk of infection following surgery. Hip and knee replacements are two of the 17 categories of surgery under surveillance by hospitals. Surveillance in at least one orthopaedic surgical category per quarter, per financial year is mandatory for all National Health Service hospitals undertaking orthopaedic surgery, with hip and knee replacements being the most numerous.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 17/05/2024 11:48:26 answering member 4044 label Biography information for Andrew Stephenson
tabling member	178 label Biography information for John McDonnell

1717159

registered interest
date	10/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Joint Replacements: Post-operative Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help tackle post-operative infections in the context of (a) an ageing population and (b) trends in the number of joint replacement operations.
tabling member constituency	Hayes and Harlington
tabling member printed	John McDonnell
uin	25604
answer	answer is ministerial correction date of answer 16/05/2024 answer text <p>The UK Health Security Agency manages a national surveillance programme, the Surgical Site Infection (SSI) Surveillance Service, which enhances the quality of patient care by providing hospitals with a framework for collection and comparison of their rates of SSI against national benchmarks. This information is used to review and guide clinical practice to reduce the risk of infection following surgery. Hip and knee replacements are two of the 17 categories of surgery under surveillance by hospitals. Surveillance in at least one orthopaedic surgical category per quarter, per financial year is mandatory for all National Health Service hospitals undertaking orthopaedic surgery, with hip and knee replacements being the most numerous.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/05/2024 13:55:11 answering member 4044 label Biography information for Andrew Stephenson
tabling member	178 label Biography information for John McDonnell

1717160

registered interest
date	10/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Joint Replacements: Post-operative Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that best practice guidelines for prosthetic infection are implemented across elective surgery clinical care pathways.
tabling member constituency	Hayes and Harlington
tabling member printed	John McDonnell
uin	25605
answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>The Government is working with NHS England to improve perioperative care. This should ensure best practice guidelines are implemented across surgery clinical care pathways, including for prosthetic infections. In May 2023, NHS England published guidance setting out five core perioperative care requirements relating to the care of adult patients awaiting planned inpatient surgery. These measures address the key objective of identifying health needs as early as possible in perioperative pathways, and then using time on the waiting list to optimise health. The NHS England National Elective Recovery and Outpatients programme is working with NHS England regional teams to help oversee and support compliance, and will continue to do so throughout 2024/25.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 14/05/2024 16:56:42 answering member 4044 label Biography information for Andrew Stephenson
tabling member	178 label Biography information for John McDonnell

1717162

registered interest
date	10/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer and Joint Replacements: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential merits of expanding the holistic care approach for cancer (a) care and (b) delivery to (i) prosthetic infection and (ii) other clinical conditions.
tabling member constituency	Hayes and Harlington
tabling member printed	John McDonnell
uin	25607
answer	answer is ministerial correction date of answer 16/05/2024 answer text <p>The Department has not made a formal assessment of the merits of expanding the holistic approach, used for cancer, to prosthetic infection and other clinical conditions, however the National Health Service is working towards a holistic approach in infection prevention and control, and in long-term conditions. This includes improving perioperative care for surgical clinical care pathways, including for prosthetic infections, whereby patients receive proactive, personalised support to optimise their health before surgery.</p><p>The NHS works hard to deliver care to meet people’s needs as far as possible, given this can have a significant impact on their experience and quality of life. Cancer Alliances across England are working to ensure that every person receives personalised care and support from cancer diagnosis onwards. This involves holistic need assessments to ensure people's physical, practical, emotional, and social needs are identified and addressed at the earliest opportunity. It also involves accessible information about emotional support, coping with side effects, financial advice, getting back to work, and making healthy lifestyle choices, before, during, and after treatment.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/05/2024 13:51:44 answering member 4044 label Biography information for Andrew Stephenson
tabling member	178 label Biography information for John McDonnell

1717172

registered interest
date	10/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Thalassaemia: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions she has had with NHS England on the introduction of (a) gene therapy and (b) other new treatments for patients with thalassaemia.
tabling member constituency	Enfield, Southgate
tabling member printed	Bambos Charalambous
uin	25665
answer	answer is ministerial correction date of answer 16/05/2024 answer text <p>The Department regularly discusses a range of issues with colleagues in NHS England related to patient access to new medicines. The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether all new medicines should be routinely funded by the NHS, based on an assessment of their costs and benefits. The NICE’s appraisal of the gene therapy, exagamglogene autotemcel, for treating transfusion-dependent beta-thalassaemia is currently paused, to allow the company and NHS England to enter into commercial and managed access discussions.</p><p>In November 2023, NHS England published a clinical commissioning policy that recommends that allogeneic haematopoietic stem cell transplantation for adult transfusion dependent thalassaemia should be routinely commissioned.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/05/2024 13:59:22 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4610 label Biography information for Bambos Charalambous

1717175

registered interest
date	10/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Defibrillators
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the adequacy of access to defibrillators.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	25679
answer	answer is ministerial correction date of answer 16/05/2024 answer text <p>To improve survival rates for out-of-hospital cardiac arrest cases, the Government launched a new £1 million one-off fund that will expand community access to Automated External Defibrillators (AEDs). The grant was made available from September 2023.</p><p>We estimated 1,000 new defibrillators would be provided by the fund, with the potential for this to double, as most applicants would be asked to match the funding they receive partially or fully. To date, the grant has successfully delivered 2,000 AEDs.</p><p>Research has shown that those in the most deprived areas of England had to travel over one kilometre to their nearest accessible, nonstop service public access defibrillator, which tended to be 99.2 metres further away than in the least deprived areas.</p><p>Applications for AEDs are selected in line with criteria to provide AEDs where there is greatest need. The criteria include remote communities with extended ambulance response times, places with high footfall and high population densities, hotspots for cardiac arrest including sporting venues and venues with vulnerable people, and deprived areas.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/05/2024 08:33:08 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4656 label Biography information for Layla Moran